Efficacy of Montelukast on STEMl Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 512 participants.
Also called NCT07320625
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 512 participants
- Sponsor
- Registry
-
NCT07320625
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07320625. Randomized; triple masking; primary purpose treatment. Start 2026-02-01 (anticipated); primary completion 2027-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Montelukast on STEMl Patients
- Condition
- Myocardial Infarction (MI)
- Intervention (Drug)
- Montelukast
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct07320625- Content hash
151ba0bc67d573c196643430451b565e6cc1d4314abf4203555cf1eaaaf5031c